What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?
Article
Dr. Charles Rudin of Memorial Sloan Kettering on how PARP inhibitors may benefit patients with small cell lung cancer. February 2014.
[powerpress]